Cysteine proteases and cysteine protease inhibitors in non-small cell lung cancer.

Abstract

In this study we investigated the levels of two lysosomal cysteine protease proteins cathepsin B (CB) and cathepsin L (CL) and the levels of three cysteine protease inhibitor proteins stefin A (SFA), stefin B (SFB) and cystatin C (CNC) in squamous-cell lung carcinoma (SQCLC) and matched lung parenchyma specimens and examined the inhibition of CB and cathepsin C (CC) activities by endogenous inhibitors in extracts from SQCLC, lung adenocarcinoma (LAC) and lung parenchyma specimens. We found that Stage I SQCLCs contained significantly increased levels of CB protein, CB activity and SFA protein as compared to matched lungs. Neither the levels of CL protein nor the levels of SFB protein nor the levels of CNC protein in Stage I SQCLCs and the lungs were significantly different, but the levels of CB and CL proteins as well as the levels of SFA and SFB proteins showed significant positive correlation in SQCLCs. In SQCLCs as well as in the lungs the level of SFB protein was significantly higher than the level of SFA protein or the level of CNC protein. In the lungs the levels of SFA protein and CNC protein revealed a weak negative correlation trend. In extracts from SQCLCs the level of SFA protein showed a weak negative correlation with the residual CB activity (i.e. the activity remaining after extract preincubation) whereas in extracts from the lungs the level of CNC protein displayed a weak negative correlation trend with the residual CB activity and with the residual CC activity. We observed that SQCLCs and LACs contained not only a significantly increased activity of CB but also a significantly higher inhibitory potential against the activity of endogenous CB as compared to matched lungs. Leupeptin, a small inhibitor of CB, was capable to protect CB in lung carcinoma and lung parenchyma extracts from preincubation-induced inhibition, revealing an active-site directed and competitive nature of CB inhibition by endogenous cystatins. Ultrafiltration passaged protein preparations of nominal Mr < or = 30,000 obtained from extracts of SQCLCs inhibited significantly higher quantities of activity of purified bovine spleen CC than did such protein preparations from matched lungs. Reaction courses of purified bovine spleen CC that had been preincubated with such protein preparations resembled those of endogenous CC from SQCLC and lung extracts showing a slow steady-state approach. These observations and the relaxation kinetics of CC from SQCLC and lung extracts suggest that CC in the extracts may be complexed with some cystatins. In conclusion, our results indicate that quantitatively different combinations of cystatins are the major constituents of the inhibitory potential against CB and CC in SQCLCs and the lungs.

• Authors: E Krepela, J Procházka, B Kárová, J Cermák, H Roubková
• Journal: Neoplasma (Neoplasma) Vol. 45 Issue 5 Pg. 318-31 ( 1998) ISSN: 0028-2685 [Print] Slovakia
• PMID: 9921922 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• CST3 protein, human
• CSTB protein, human
• Cystatin A
• Cystatin C
• Cystatins
• Cysteine Proteinase Inhibitors
• Leupeptins
• CSTA protein, human
• Cystatin B
• Cathepsins
• Endopeptidases
• Dipeptidyl-Peptidases and Tripeptidyl-Peptidases
• Cathepsin C
• Cysteine Endopeptidases
• Cathepsin B
• CTSL protein, human
• Cathepsin L
• leupeptin

Topics

• Adenocarcinoma (enzymology, metabolism)
• Adult
• Aged
• Animals
• Carcinoma, Squamous Cell (enzymology, metabolism)
• Cathepsin B (metabolism)
• Cathepsin C
• Cathepsin L
• Cathepsins (metabolism)
• Cattle
• Cystatin A
• Cystatin B
• Cystatin C
• Cystatins (metabolism)
• Cysteine Endopeptidases
• Cysteine Proteinase Inhibitors (metabolism)
• Dipeptidyl-Peptidases and Tripeptidyl-Peptidases (metabolism)
• Endopeptidases
• Female
• Humans
• Kinetics
• Leupeptins (pharmacology)
• Lung (enzymology)
• Lung Neoplasms (enzymology, metabolism)
• Lysosomes (enzymology)
• Male
• Middle Aged
• Sensitivity and Specificity